Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026
OrthoPediatrics Rg (NASDAQ Cons)
Závěr k 13.2.2026 Změna (%) Změna (USD) Objem obchodů (USD)
16,89 1,02 0,17 845 117
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.02.2026
Popis společnosti
Obecné informace
Název společnostiOrthopediatrics Corp
TickerKIDS
Kmenové akcie:Ordinary Shares
RICKIDS.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 31.12.2024 562
Akcie v oběhu k 30.09.2025 25 077 330
MěnaUSD
Kontaktní informace
Ulice2850 Frontier Drive
MěstoWARSAW
PSČ46582
ZeměUnited States
Kontatní osobaPhilip Taylor
Funkce kontaktní osobyInvestor Relations
Telefon13 026 587 581
Fax13026555049

Business Summary: OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Orthopediatrics Corp revenues increased 15% to $174.7M. Net loss increased 36% to $29.5M. Revenues reflect Trauma and Deformity segment increase of 14% to $123.7M, Scoliosis segment increase of 23% to $48.4M, U.S. segment increase of 16% to $137.8M, International segment increase of 9% to $37M. Higher net loss reflects General and administrative increase of 15% to $89.9M (expense).
Odvětvová klasifikace
TRBC2012Medical Devices & Implants
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICS2007Surgical & Medical Instrument Mfg
NAICS1997Surgical and Medical Instrument Manufacturing
SICSurgical And Medical Instruments



  • Poslední aktualizace: 14.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorDavid Bailey4603.11.202101.01.2009
Chief Financial Officer, Chief Operating Officer, DirectorFred Hite5703.06.2020
President of Trauma, Deformity and OPSBJoseph Hauser4301.01.2021
President of ScoliosisGregory Odle5501.01.2011
Executive Vice President - Legal, General Counsel, Company SecretaryDaniel Gerritzen55